These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 35325372)

  • 1. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy.
    Cai Z; Li S; Xiong Z; Lin J; Sun Y
    Sci Rep; 2024 Aug; 14(1):19090. PubMed ID: 39154103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 4. Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
    Collarino A; Feudo V; Pasciuto T; Florit A; Pfaehler E; de Summa M; Bizzarri N; Annunziata S; Zannoni GF; de Geus-Oei LF; Ferrandina G; Gambacorta MA; Scambia G; Boellaard R; Sala E; Rufini V; van Velden FH
    J Nucl Med; 2024 Jun; 65(6):962-970. PubMed ID: 38548352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
    Sun C; Tian X; Liu Z; Li W; Li P; Chen J; Zhang W; Fang Z; Du P; Duan H; Liu P; Wang L; Chen C; Tian J
    EBioMedicine; 2019 Aug; 46():160-169. PubMed ID: 31395503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
    Gui B; Autorino R; Miccò M; Nardangeli A; Pesce A; Lenkowicz J; Cusumano D; Russo L; Persiani S; Boldrini L; Dinapoli N; Macchia G; Sallustio G; Gambacorta MA; Ferrandina G; Manfredi R; Valentini V; Scambia G
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33807494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Chiloiro G; Boldrini L; Preziosi F; Cusumano D; Yadav P; Romano A; Placidi L; Lenkowicz J; Dinapoli N; Bassetti MF; Gambacorta MA; Valentini V
    Front Oncol; 2022; 12():831712. PubMed ID: 35280799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
    Cusumano D; Russo L; Gui B; Autorino R; Boldrini L; D'Erme L; Persiani S; Catucci F; Broggi S; Panza G; Nardangeli A; Campitelli M; Ferrandina G; Macchia G; Fiorino C; Valentini V; Scambia G; Manfredi R; Gambacorta MA
    Radiother Oncol; 2022 Sep; 174():30-36. PubMed ID: 35811004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
    Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
    Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.
    Wu RR; Zhou YM; Xie XY; Chen JY; Quan KR; Wei YT; Xia XY; Chen WJ
    Sci Rep; 2023 Nov; 13(1):19409. PubMed ID: 37938596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
    Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
    Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
    Lucia F; Visvikis D; Vallières M; Desseroit MC; Miranda O; Robin P; Bonaffini PA; Alfieri J; Masson I; Mervoyer A; Reinhold C; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):864-877. PubMed ID: 30535746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.